Purinergic signaling in the battlefield of viral infections
- PMID: 38038801
- DOI: 10.1007/s11302-023-09981-8
Purinergic signaling in the battlefield of viral infections
Abstract
Purinergic signaling has been associated with immune defenses against pathogens such as bacteria, protozoa, fungi, and viruses, acting as a sentinel system that signals to the cells when a threat is present. This review focuses on the roles of purinergic signaling and its therapeutic potential for viral infections. In this context, the purinergic system may play potent antiviral roles by boosting interferon signaling. In other cases, though, it can contribute to a hyperinflammatory response and disease severity, resulting in poor outcomes, such as during flu and potentially COVID-19. Lastly, a third situation may occur since viruses are obligatory intracellular parasites that hijack the host cell machinery for their infection and replication. Viruses such as HIV-1 use the purinergic system to favor their infection and persistence within the host cell. Therefore, understanding the particular nuances of purinergic signaling in each viral infection may contribute to designing proper therapeutic strategies to treat viral diseases.
Keywords: Hyperinflammation; Innate antiviral immune; Purinergic signaling; Viral infection.
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Innate antiviral immune signaling, viral evasion and modulation by HIV-1.J Mol Biol. 2014 Mar 20;426(6):1161-77. doi: 10.1016/j.jmb.2013.12.003. Epub 2013 Dec 8. J Mol Biol. 2014. PMID: 24326250 Free PMC article. Review.
-
HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection.mBio. 2017 May 2;8(3):e01518-16. doi: 10.1128/mBio.01518-16. mBio. 2017. PMID: 28465428 Free PMC article.
-
Proteomics to study macrophage response to viral infection.J Proteomics. 2018 May 30;180:99-107. doi: 10.1016/j.jprot.2017.06.018. Epub 2017 Jun 21. J Proteomics. 2018. PMID: 28647517 Review.
-
Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state.Immunol Rev. 2010 May;235(1):128-46. doi: 10.1111/j.0105-2896.2010.00909.x. Immunol Rev. 2010. PMID: 20536560 Review.
-
Purinergic Signaling: A New Pharmacological Target Against Viruses?Trends Pharmacol Sci. 2018 Nov;39(11):926-936. doi: 10.1016/j.tips.2018.09.004. Epub 2018 Oct 3. Trends Pharmacol Sci. 2018. PMID: 30292585 Review.
References
-
- Lohmann K (1929) über die Pyrophosphatfraktion im Muskel. Naturwissenschaften 17(31):1. https://doi.org/10.1007/BF01506215 - DOI
-
- Burnstock G, Campbell G, Satchell D, Smythe A (1970) Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40(4):668–688. https://doi.org/10.1111/j.1476-5381.1970.tb10646.x - DOI - PubMed - PMC
-
- Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24(3):509–581 https://www.ncbi.nlm.nih.gov/pubmed/4404211 - PubMed
-
- Coutinho-Silva R, Savio LEB (2021) Purinergic signalling in host innate immune defence against intracellular pathogens. Biochem Pharmacol 187:114405. https://doi.org/10.1016/j.bcp.2021.114405 - DOI - PubMed
-
- Mut-Arbona P, Sperlagh B (2023) P2 receptor-mediated signaling in the physiological and pathological brain: from development to aging and disease. Neuropharmacology 233:109541. https://doi.org/10.1016/j.neuropharm.2023.109541 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources